Health Care & Life Sciences » Biotechnology | Shanghai Kehua Bio-Engineering Co. Ltd.

Shanghai Kehua Bio-Engineering Co. Ltd. A | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,104
1,210
1,147
1,383
1,584
1,978
Cost of Goods Sold (COGS) incl. D&A
587
682
694
847
987
1,249
Gross Income
517
527
453
536
597
729
SG&A Expense
197
202
241
286
345
469
EBIT
316
323
202
252
245
262
Unusual Expense
-
-
-
-
2
-
Non Operating Income/Expense
3
1
35
16
8
44
Interest Expense
-
2
-
4
4
14
Pretax Income
352
350
248
275
267
299
Income Tax
55
53
38
41
46
52
Equity in Affiliates
-
4
3
3
3
-
Consolidated Net Income
301
300
210
231
221
247
Net Income
288
292
211
232
218
208
Net Income After Extraordinaries
288
292
211
232
218
208
Net Income Available to Common
288
292
211
232
218
208
EPS (Basic)
0.59
0.59
0.42
0.45
0.42
0.41
Basic Shares Outstanding
492
492
506
513
513
513
EPS (Diluted)
0.59
0.59
0.42
0.45
0.42
0.40
Diluted Shares Outstanding
492
492
506
513
513
514
EBITDA
344
356
246
310
314
350
Other Operating Expense
4
2
9
2
8
2
Non-Operating Interest Income
11
9
1
11
17
8
Minority Interest Expense
13
8
1
2
4
39

About Shanghai Kehua Bio-Engineering Co.

View Profile
Address
No. 1189 North Qinzhou Road
Shanghai Shanghai 200233
China
Employees -
Website http://www.skhb.com
Updated 07/08/2019
Shanghai Kehua Bio-Engineering Co., Ltd. engages in the manufacture and marketing of vitro diagnostic products. The company was founded in November, 1981 and is headquartered in Shanghai, China. .